Potential probiotic application of a novel commensal E. coli strain with antagonistic activity against different enteric pathogens.
Diarrheal diseases remain a leading cause of global morbidity and mortality, with treatment options increasingly compromised by the global rise of multidrug-resistant (MDR) pathogens. Furthermore, the absence of effective vaccines against many causative agents leaves large populations vulnerable. This critical gap nece...